| Recent Advances in Machine Learning Methods for Predicting Heat Shock Proteins |
46 |
| Machine Learning in Quantitative Protein-peptide Affinity Prediction: Implications for Therapeutic Peptide Design |
22 |
| Replacing GHB with GBL in Recreational Settings: A New Trend in Chemsex |
21 |
| Medicinal and Therapeutic Potential of Herbs and Plant Metabolites / Extracts Countering Viral Pathogens - Current Knowledge and Future Prospects |
20 |
| Survey of Machine Learning Techniques in Drug Discovery |
19 |
| The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics |
19 |
| Long Circulating Polymeric Nanoparticles for Gene/Drug Delivery |
18 |
| Essential Oils: Extraction Techniques, Pharmaceutical And Therapeutic Potential - A Review |
17 |
| Models of Drug Induced Liver Injury (DILI) - Current Issues and Future Perspectives |
14 |
| Magnetic Nanoparticles: Current Trends and Future Aspects in Diagnostics and Nanomedicine |
13 |
| Natural Plant Products for he Treatmentof Neurological Disorders: Current Knowledge |
12 |
| Indoles - Gut Bacteria Metabolites of Tryptophan with Pharmacotherapeutic Potential |
12 |
| Role of Mitochondrial Mechanism in Chemotherapy-Induced Peripheral Neuropathy |
12 |
| The Application of Natural Products in Cancer Therapy by Targeting Apoptosis Pathways |
11 |
| Anti-Cancer Effects of Metformin: Recent Evidences for its Role in Prevention and Treatment of Cancer |
10 |
| Cancer Nanotechnology: A New Revolution for Cancer Diagnosis and Therapy |
10 |
| Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation |
10 |
| Targeting Virus-host Protein Interactions: Feature Extraction and Machine Learning Approaches |
10 |
| Herbal Immunomodulators - A Remedial Panacea for Designing and Developing Effective Drugs and Medicines: Current Scenario and Future Prospects |
10 |
| Plant-Derived Polyphenols in Human Health:Biological Activity, Metabolites and Putative Molecular Targets |
10 |
| Tacrolimus - Pharmacokinetic Considerations for Clinicians |
10 |
| Adverse Events of Proton Pump Inhibitors: Potential Mechanisms |
9 |
| Herb-Drug Interactions and Hepatotoxicity |
9 |
| Advances in Long-Circulating Drug Delivery Strategy |
9 |
| An Insight into the Therapeutic Potential of Major Coffee Components |
9 |
| Drug-drug Interactions of P-gp Substrates Unrelated to CYP Metabolism |
8 |
| Kidney-on-a-Chip: A New Technology for Predicting Drug Efficacy, Interactions, and Drug-Induced Nephrotoxicity |
8 |
| Current Designs of Polymer Blends in Solid Dispersions for Improving Drug Bioavailability |
8 |
| Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner |
8 |
| Pharmacokinetics, Metabolism, Distribution and Permeability of Nanomedicine |
8 |
| Survey of Machine Learning Techniques for Prediction of the Isoform Specificity of Cytochrome P450 Substrates |
7 |
| Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability |
7 |
| Cross-regulatory Circuit Between AHR and Microbiota |
7 |
| Recent Advances in the Machine Learning-based Drug-target Interaction Prediction |
6 |
| Preclinical Hepatoprotective Effect of Herbalism Against Ethanol Induced Hepatotoxicity: A Review |
6 |
| Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies |
6 |
| Current Therapeutic Approaches for Targeting Inflammation in Depression and Cardiovascular Disease |
6 |
| Drug-induced Cholestasis: Mechanisms, Models, and Markers |
6 |
| Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease |
5 |
| Glycogen Synthase Kinase-3 beta as a Putative Therapeutic Target for Bipolar Disorder |
5 |
| Methotrexate Overdose in Clinical Practice |
5 |
| A Review of Recent Advances and Research on Drug Target Identification Methods |
5 |
| Total Sleep Duration and Risk of Type 2 Diabetes: Evidence-Based On Clinical and Epidemiological Studies |
5 |
| Deaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom Communities Associated with GHB and Precursors |
5 |
| Metabolism of the Dual Orexin Receptor Antagonist ACT-54 Based on Microtracer/Accelerator Mass Spectrometry |
5 |
| Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions |
5 |
| Impact of Drug Metabolism/Pharmacokinetics and their Relevance Upon Traditional Medicine-based Cardiovascular Drug Research |
5 |
| Recent Advances in Gold Nanoformulations for Cancer Therapy |
5 |
| New Therapeutic Drugs from Bioactive Natural Molecules: The Role of Gut Microbiota Metabolism in Neurodegenerative Diseases |
5 |
| Anti-leishmanial Nanotherapeutics: A Current Perspective |
5 |
